Is there an attempt "to flush out would-be whistle-blowers" at the National Institute of Environmental Health Sciences, which "focuses on how pollution and other toxins in the environment contribute to disease"?
Following Dr. Steven Nissen's publication of a study warning that "GlaxoSmithKline's diabetes drug Avandia increased the risk of heart attacks by 43% and death from cardiovascular events by possibly 64%," he was publicly pilloried. "More than one story from ostensibly different sources" derisively referred to him as "St Steven," the "Patron Saint of Drug Safety," and "Saint Steven the Pure," reports Evelyn Pringle. Among the attackers was FDA spokesman Douglas Arbesfeld.
"The increasing number of attacks by lobby groups on the US cosmetics and personal care industry means that it is time to fight back," according to CosmeticsDesign.com. The main industry group, the Cosmetic, Toiletry, and Fragrance Association (CTFA), will "use the internet ...
Martin Durkin, the director of the global warming sceptic film, The Great Global Warming Swindle, concedes that a graph he used of temperatures over the last thousand years ignores data from the last twenty years. In Durkin's film the endpoint of the graph, produced by a British academic back in the 1980's, is labelled "now".
In testimony before Congress, former U.S. Surgeon General Richard H. Carmona accused the Bush administration on Tuesday of muzzling him on sensitive public health issues.
David Hancocks, a former director and architect of zoos in the United States and Australia, is skeptical of the conservation benefits often claimed by zoos. While many zoos tout breeding as a success story, Hancocks sees it as "merely basic zoo business: zoos must breed their animals to preserve their collections. Hardly any animals born in zoos are introduced to the wild." Despite this, he wrote in an opinion column, "They nonetheless loudly position themselves as leaders in wildlife conservation.
Several members of Congress are asking about conflicts of interest at the U.S. Food and Drug Administration after an FDA spokesman, who previously worked as a public relations representative for pharmaceutical companies, used agency email to attack the research of an independent scientist. Douglas Arbesfeld, a senior communications consultant to the FDA, sent an email to reporters attacking Dr.
In the wake of the latest study showing heart attack risk in an FDA-approved drug, there have been increased calls for greater transparency of clinical trial results. What does the U.S. Food and Drug Administration think about requiring companies to publicly release all of their trial results?